Vishal Jhanji, MD, FRCS(Glasgow), FRCOphth, FARVO

  • Professor of Ophthalmology
  • Director, Cornea Service, UPMC Ophthalmology
  • Vice Chair, Quality, UPMC Ophthalmology
  • Co-Director, Clinical Trials, UPMC Ophthalmology
  • Clinical Codirector of the Funderburgh Cornea Regeneration project

A Conversation With Dr. Jhanji

Dr. Vishal Jhanji is a Professor of Ophthalmology at the University of Pittsburgh School of Medicine. He is a corneal specialist and a clinician scientist by training. Dr. Jhanji completed his ophthalmology training from the prestigious All India Institute of Medical Sciences in New Delhi, India and his fellowship from the Royal Victorian Eye and Ear Hospital, University of Melbourne, Australia. He worked as an Associate Professor in the Department of Ophthalmology and Visual Sciences, at the Chinese University of Hong Kong. In 2017, Dr. Jhanji joined as a Professor at the University of Pittsburgh School of Medicine. He is the current president of the Eye and Contact Lens Association.

Positions

Vice Chair Clinical Operations
Director, Quality Control
Director, Clinical Trials
Clinical Co-director, Corneal Regeneration Laboratory
Associate Medical Director, The Charles T. Campbell Ophthalmic Microbiology Laboratory

Representative Publications


1. Singh RB, Parmar UPS, Jhanji V. Prevalence and Economic Burden of Keratoconus in the United States. Am J Ophthalmol. 2023 Nov 10;259:71-78. doi: 10.1016/j.ajo.2023.11.009.


2. Shanks RMQ, Atta S, Stella NA, Sundar-Raj CV, Romanowski JE, Grewal AS, Shanks HQ, Mumper SM, Dhaliwal DK, Mammen A, Callaghan JD, Calvario RC, Romanowski EG, Kowalski RP, Zegans ME, Jhanji V. A rise in the frequency of lasR mutant Pseudomonas aeruginosa among keratitis isolates between 1993 and 2021. Front Cell Infect Microbiol. 2023 Oct 31;13:1286842. doi: 10.3389/fcimb.2023.1286842.


3. Prakash G, Mammen A, Jhanji V. Rate of fractional change in corneal tomography parameters in keratoconus using a combination of predictive parameters. Eye Vis (Lond). 2023 Oct 1;10(1):40. doi: 10.1186/s40662-023-00357-y.


4. Zhang BN, Qi B, Chu WK, Song F, Li S, Dong Q, Shao Z, Zhang B, Du X, Ma X, Jhanji V, Zhou Q. Norepinephrine as the Intrinsic Contributor to Contact Lens-Induced Pseudomonas aeruginosa Keratitis. Invest Ophthalmol Vis Sci. 2023 May 1;64(5):26. doi: 10.1167/iovs.64.5.26.


5. Sun Z, Li Z, Chung JT, Lau LCM, Jhanji V, Chau Y. Low-intensity low-frequency ultrasound mediates riboflavin delivery during corneal crosslinking. Bioeng Transl Med. 2022 Nov 25;8(2):e10442. doi: 10.1002/btm2.10442. eCollection 2023 Mar.


6. Yam GH, Yang T, Geary ML, Santra M, Funderburgh M, Rubin E, Du Y, Sahel JA, Jhanji V, Funderburgh JL. Human corneal stromal stem cells express anti-fibrotic microRNA-29a and 381-5p - A robust cell selection tool for stem cell therapy of corneal scarring. J Adv Res. 2023 Mar;45:141-155. doi: 10.1016/j.jare.2022.05.008. Epub 2022 May 25.


7. Sugar A, Hussain M, Chamberlain W, Dana R, Kelly DP, Ta C, Irvine J, Daluvoy M, Perez V, Olson J, Jhanji V, Walts TA, Stulting RD, Waller EK, Jagirdar N; Cambium Dry Eye Study Group. A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease. Ophthalmol Sci. 2022 Jun 2;2(3):100176. doi: 10.1016/j.xops.2022.100176. eCollection 2022 Sep.

Research Interests

  1. Complex ocular surface disorders (Graft versus host disease, Stevens Johnson syndrome, Cicatricial disorders)
  2. Keratoconus, other corneal ectasias and collagen crosslinking
  3. Corneal infections
  4. Corneal transplantation
  5. Imaging of the cornea